These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36415837)

  • 21. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection.
    Colomba C; Di Carlo P; Guadagnino G; Siracusa L; Trizzino M; Gioè C; Cascio A
    Infect Agent Cancer; 2016; 11():25. PubMed ID: 27257433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
    Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors.
    De Benedetto I; Barco A; Rossi M; Lapadula G; Lupia T; Bonfanti P; Bonora S; Di Perri G; Calcagno A
    Infez Med; 2022; 30(2):242-246. PubMed ID: 35693064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCG Aortitis, a Rare Complication of BCG Therapy.
    Haddad J; Chalret du Rieu H; Ducasse E; Berard X; Caradu C
    EJVES Vasc Forum; 2023; 58():23-27. PubMed ID: 36949865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary aortoenteric fistula after intravesical instillation of Bacillus Calmette-Guérin for bladder cancer.
    Lorenzo JF; López Arquillo IM; Rey JV
    Vascular; 2024 Oct; 32(5):952-956. PubMed ID: 37148206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
    Fujita N; Hatakeyama S; Momota M; Kido K; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Aug; 38(8):684.e17-684.e24. PubMed ID: 32278732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulomatous hepatitis and hemophagocytic syndrome after bacillus Calmette-Guerin bladder instillation.
    Thevenot T; Di Martino V; Lagrange A; Petrella T; Faucher JF; Fontan J; Terebus M; Miguet JP; Bresson-Hadni S
    Gastroenterol Clin Biol; 2006 Mar; 30(3):480-2. PubMed ID: 16633319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer.
    Vilares AT; Nunes Silva C; Correia da Silva M; Sousa J; Viamonte B; Madureira AJ
    Radiol Case Rep; 2022 Jul; 17(7):2383-2387. PubMed ID: 35570860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [BCG-induced (bacillus Calmette-Guérin) abdominal granulomatosis after occult bladder perforation].
    Lawaczeck L; Fischer AK; Norz V; Rausch S; Bedke J; Stenzl A; Amend B
    Urologe A; 2021 Sep; 60(9):1184-1187. PubMed ID: 34100955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.
    Elzein F; Albogami N; Saad M; El Tayeb N; Alghamdi A; Elyamany G
    Clin Med Insights Case Rep; 2016; 9():71-3. PubMed ID: 27559301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
    Vallilas C; Zachou M; Dolkiras P; Sakellariou S; Constantinou CA; Flevari P; Anastasopoulou A; Androutsakos T
    Am J Case Rep; 2021 Oct; 22():e933006. PubMed ID: 34654796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
    Koga H; Kuroda M; Kudo S; Yamaguchi A; Usami M; Suzuki T; Naito S
    Int J Urol; 2005 Feb; 12(2):145-51. PubMed ID: 15733108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute reactive arthritis after intravesical instillation of bacillus Calmette-Guérin. Two case reports and literature review].
    Miranda S; Verdet M; Héron F; Vittecoq O; Levesque H; Marie I
    Rev Med Interne; 2010 Aug; 31(8):558-61. PubMed ID: 20494494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer.
    Riccardi N; Ferrarese M; Castellotti P; Mazzola E; Sozzi F; Rigatti P; Vanzulli A; Sotgiu G; Codecasa L
    Urologia; 2020 Nov; 87(4):199-202. PubMed ID: 31271544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors.
    Lüftenegger W; Ackermann DK; Futterlieb A; Kraft R; Minder CE; Nadelhaft P; Studer UE
    J Urol; 1996 Feb; 155(2):483-7. PubMed ID: 8558641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.